BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23681799)

  • 1. C282Y polymorphism in the HFE gene is associated with risk of breast cancer.
    Liu X; Lv C; Luan X; Lv M
    Tumour Biol; 2013 Oct; 34(5):2759-64. PubMed ID: 23681799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis of the Association between H63D and C282Y Polymorphisms in HFE and Cancer Risk.
    Zhang M; Xiong H; Fang L; Lu W; Wu X; Wang YQ; Cai ZM; Wu S
    Asian Pac J Cancer Prev; 2015; 16(11):4633-9. PubMed ID: 26107216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
    Xia J; Xu H; Jiang H; Xie J
    Neurosci Lett; 2015 May; 595():99-103. PubMed ID: 25863172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implicating the H63D polymorphism in the HFE gene in increased incidence of solid cancers: a meta-analysis.
    Shen LL; Gu DY; Zhao TT; Tang CJ; Xu Y; Chen JF
    Genet Mol Res; 2015 Oct; 14(4):13735-45. PubMed ID: 26535689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age.
    Shi Z; Johnstone D; Talseth-Palmer BA; Evans TJ; Spigelman AD; Groombridge C; Milward EA; Olynyk JK; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2009 Jul; 125(1):78-83. PubMed ID: 19291797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.
    Osborne NJ; Gurrin LC; Allen KJ; Constantine CC; Delatycki MB; McLaren CE; Gertig DM; Anderson GJ; Southey MC; Olynyk JK; Powell LW; Hopper JL; Giles GG; English DR
    Hepatology; 2010 Apr; 51(4):1311-8. PubMed ID: 20099304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer.
    Gunel-Ozcan A; Alyilmaz-Bekmez S; Guler EN; Guc D
    BMC Cancer; 2006 Feb; 6():37. PubMed ID: 16503999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
    Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
    BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.
    Li M; Wang L; Wang W; Qi XL; Tang ZY
    Braz J Med Biol Res; 2014 Feb; 47(3):215-22. PubMed ID: 24604426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.
    Lv YF; Chang X; Hua RX; Yan GN; Meng G; Liao XY; Zhang X; Guo QN
    J Cell Mol Med; 2016 Jul; 20(7):1219-33. PubMed ID: 26893171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population.
    Lin A; Yan WH; Xu HH; Zhu M; Zhou MY
    Tissue Antigens; 2007 Sep; 70(3):252-5. PubMed ID: 17661915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men.
    Pedersen P; Melsen GV; Milman N
    Ann Hematol; 2008 Sep; 87(9):735-40. PubMed ID: 18542962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE gene polymorphisms and the risk for autism in Egyptian children and impact on the effect of oxidative stress.
    Gebril OH; Meguid NA
    Dis Markers; 2011; 31(5):289-94. PubMed ID: 22048270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
    Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A
    J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis.
    Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC
    Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania.
    Trifa AP; Popp RA; Militaru MS; Farcaş MF; Crişan TO; Gana I; Cucuianu A; Pop IV
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.
    Chen W; Zhao H; Li T; Yao H
    Tumour Biol; 2013 Aug; 34(4):2255-9. PubMed ID: 23553028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.